- Exchange: Frankfurt
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
Kainos Laboratories Inc
+ Add to WatchlistKA3:GR
4.589 EUR 0.007 0.15%As of 09:32:26 ET on 06/19/2013.
Snapshot for Kainos Laboratories Inc (KA3)
| Open: | 4.589 | Day's Range: | 4.589 - 4.589 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 4.596 | 52wk Range: | 2.309 - 9.241 | 1-Yr Rtn: | +96.80% |
Key Statistics for KA3
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 21 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.28% |
| Cash Dividend (JPY) | 7.5000 |
| Last Dividend | 03/27/2014 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for KA3
Company Profile & Key Executives for KA3
KAINOS Laboratories, Inc. manufactures and sells clinical reagents. The Company specializes in biochemical reagents as well as immune serum studies. Kainos Laboratories produces in-house products including measuring equipment and tools through focus on research and development. The Company also has a close relation with Hitachi Chemical Company for technological tie-up.
| Toshimichi NakamuraChairman | Shiro KamijiPresident |
| Koshi TokunagaSenior Managing Director | Hiroshi UeharaDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
KA3 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page